← Back to Search

Educational Video and Question Prompt List for Glaucoma

N/A
Waitlist Available
Led By Betsy Sleath, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
African American
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial is testing how well a provider communicates with an African American patient about glaucoma in order to improve care.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
None. (It is not appropriate or ethical to exclude individuals based on race.)

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Glaucoma Medication Adherence Self-Efficacy Score
Glaucoma Medication Percent Adherence
Intraocular Pressure

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Question Prompt List and VideoExperimental Treatment1 Intervention
Participants will watch an educational video and question prompt list will be provided. Glaucoma visits will be audio-taped. A 15-20-minute interview will be conducted after the visit by a research assistant.
Group II: Usual CareActive Control1 Intervention
The usual care group will not receive any intervention. Glaucoma visits will be audio-taped. A 15-20-minute interview will be conducted after the visit by a research assistant.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Educational Video and Question Prompt List
2018
N/A
~550

Find a Location

Who is running the clinical trial?

Agency for Healthcare Research and Quality (AHRQ)FED
398 Previous Clinical Trials
7,088,570 Total Patients Enrolled
1 Trials studying Glaucoma
2,597 Patients Enrolled for Glaucoma
University of North Carolina, Chapel HillLead Sponsor
1,499 Previous Clinical Trials
4,176,134 Total Patients Enrolled
2 Trials studying Glaucoma
38 Patients Enrolled for Glaucoma
Betsy Sleath, PhDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill
1 Previous Clinical Trials
140 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
South Carolina
What site did they apply to?
University of North Carolina at Chapel Hill
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

Lost vision in my left eye.
PatientReceived 1 prior treatment
~29 spots leftby Mar 2025